Slovaquie

Bienvenue ! Sur cette page, vous trouverez toutes les dernières actualités juridiques, publications et événements pour Slovaquie. Pour rester informés des dernières évolutions, veuillez ajouter cette page à vos favoris sur votre mobile ou vous inscrire pour recevoir les eAlerts.

CMS est un acteur majeur en Slovaquie : pour en savoir plus, cliquez ici.

eAlerts Récentes

  •  
    24/05/2024
    Europe

    EU anti-dumping investigations for Chinese lysine and vanillin imports

    On 23 May 2024, the EU opened an anti-dumping investigation concerning EU imports of lysine originating in the People’s Republic of China, which could lead to substantial anti-dumping duties on future imports.On 24 May 2024, the EU opened another anti-dumping investigation concerning EU imports of vanillin originating in the People’s Republic of China, which could lead to substantial anti-dumping duties on future imports.Lysine investigationThe products under investigation for alleged dumping are “lysine and its esters, salts thereof, and feed additives, consisting...
    Lire la suite
  •  
    22/05/2024
    Europe

    The EU Gigabit Infrastructure Act: Faster, Cheaper and Simpler Rollout of High-Speed Networks

    The EU Gigabit Infrastructure Act (GIA), which is set to become law after a political agreement reached in February 2024, responds to the ever-growing need for faster, more reliable, data-intensive connectivity in Europe. The key purpose of the GIA is to replace the 2014 Broadband Cost Reduction Directive and to facilitate the rollout of very high-capacity networks (VHCN) by addressing identified roadblocks such as expensive and complex procedures for network deployment. It is part of the EU’s wider goal of deploying gigabit-capable infrastructure across the EU by 2030.Main Objectives...
    Lire la suite
  •  
    21/05/2024
    EU

    Consultation de la Commission européenne sur les engagements de Vifor concernant le dénigrement abusif potentiel de la médecine du fer

    GB
    Dans le cadre d'une enquête lancée en 2022 à l'encontre de Vifor concernant un potentiel dénigrement abusif à l'encontre de son concurrent, Pharmacosmos, la Commission européenne a lancé le 19 avril 2024 une consultation sur les engagements proposés par Vifor pour mettre fin à la procédure, notamment une campagne de communication, l'abstention de certaines activités promotionnelles et la mise en œuvre de mesures de conformité.ContexteEn juin 2022, la Commission européenne a ouvert une enquête formelle...
    Lire la suite
  •  
    17/05/2024
    Europe

    European Sanctions: Mandatory Contract Clauses, New Criminal Penalties

    BackgroundFollowing Russia’s occupation of Crimea in 2014 and invasion of Ukraine in 2022, global allies including the UK, US and EU, Canada and Australia, acted in concert to impose stringent sanctions and export control restrictions designed to stem the flow of investment into the Russian war machine. These included wide restrictions on the goods and their components found on the battlefield in Ukraine, and is reflected in the G7 agreed list of Common High Priority Items.The two years since have seen the growth of a shadow “evasion” economy, used by supporters of the Russian...
    Lire la suite
  •  
    16/05/2024
    Europe

    A broader interpretation of "substance or composition" - good news for patentees at the EPO?

    A recent decision from the EPO Boards of Appeal (T 1252/20) potentially paves the way for more diverse products to be patentable in Europe using the medical use claim format.The background:Article 53(c) of the European Patent Convention (EPC) excludes methods for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body from patentability. However, this does not apply to products, in particular substances or compositions, for use in any of these methods.Furthermore, Articles 54(4) and (5) EPC provide that a claim to a known substance...
    Lire la suite
  •  
    15/05/2024
    EU

    The European Commission reports on the open and targeted consultations on the SFDR assessment

    BackgroundThe Sustainable Finance Disclosures Regulation (SFDR1) applies since March 2021 with a view to providing transparency to investors about the sustainability risks associated with their investments and potential adverse impacts such investments have on the environment and society.On 14 September 2023, the European Commission (the EC) published two consultation papers on SFDR. On the one hand, an open consultation on the practical implementation of SFDR aimed at a broader range of stakeholders with a more general knowledge of SFDR (the Open Consultation). On the other hand, a target consultation...
    Lire la suite